<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; FDA</title>
	<atom:link href="http://oralcancernews.org/wp/tag/fda/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Mon, 06 Feb 2012 22:09:34 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>HPV Vaccine Not Linked To Autoimmune Disorders, Study</title>
		<link>http://oralcancernews.org/wp/hpv-vaccine-not-linked-to-autoimmune-disorders-study/</link>
		<comments>http://oralcancernews.org/wp/hpv-vaccine-not-linked-to-autoimmune-disorders-study/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 17:32:47 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[hpv vaccine]]></category>
		<category><![CDATA[Journal of Internal Medicine]]></category>
		<category><![CDATA[Kaiser Permanente Department of Research & Evaluation]]></category>
		<category><![CDATA[Merck & Co.]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12406</guid>
		<description><![CDATA[Source: MedicalNewsToday.com A two-year study of nearly 190,000 girls and women, finds that Gardasil, the human papillomavirus (HPV) vaccine made by Merck &#38; Co, does not trigger autoimmune disorders such as lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis. The results are published in the Journal of Internal Medicine. Study lead author Dr Chun [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-vaccine-not-linked-to-autoimmune-disorders-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Third Head and Neck Indication for Erbitux</title>
		<link>http://oralcancernews.org/wp/new-indication-for-cetuximab-in-squamous-cell-carcinoma-of-the-head-and-neck/</link>
		<comments>http://oralcancernews.org/wp/new-indication-for-cetuximab-in-squamous-cell-carcinoma-of-the-head-and-neck/#comments</comments>
		<pubDate>Thu, 05 Jan 2012 18:03:40 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[colorectal cancer]]></category>
		<category><![CDATA[erbitux]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[radiation therapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[squamous cell head and neck cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12267</guid>
		<description><![CDATA[Source: The ASCO Post, January 1, 2012, Volume 3, Issue 1, Matthew Stenger &#160; In the Clinic provides overviews of novel oncology agents, addressing indications, mechanisms, administration recommendations, safety profiles, and other essential information needed for the appropriate clinical use of these drugs.Cetuximab (Erbitux) was recently approved by the FDA for use in combination with platinum-based therapy [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/new-indication-for-cetuximab-in-squamous-cell-carcinoma-of-the-head-and-neck/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>UI professors: HPV editorial misses the mark</title>
		<link>http://oralcancernews.org/wp/ui-professors-hpv-editorial-misses-the-mark/</link>
		<comments>http://oralcancernews.org/wp/ui-professors-hpv-editorial-misses-the-mark/#comments</comments>
		<pubDate>Thu, 08 Dec 2011 17:31:17 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[CDC]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV vaccines]]></category>
		<category><![CDATA[Pap smears]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12177</guid>
		<description><![CDATA[Source: The Daily Iowan The Nov. 29 editorial &#8220;Recommend Pap smears, not vaccines, to prevent cervical cancer&#8221; completely missed the mark with regard to HPV vaccines. We are researchers and clinicians at the University of Iowa who study and treat HPV and other infectious diseases. It is disturbing to think that the article might dissuade [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/ui-professors-hpv-editorial-misses-the-mark/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Use and Acceptance of HPV Vaccine Still a Work in Progress</title>
		<link>http://oralcancernews.org/wp/use-and-acceptance-of-hpv-vaccine-still-a-work-in-progress/</link>
		<comments>http://oralcancernews.org/wp/use-and-acceptance-of-hpv-vaccine-still-a-work-in-progress/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 17:44:27 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Advisory Committee on Immunization Practices]]></category>
		<category><![CDATA[anal cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[CDC]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[Division of Cancer Control and Population Sciences]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[HPV 18]]></category>
		<category><![CDATA[HPV-16]]></category>
		<category><![CDATA[NCI]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12139</guid>
		<description><![CDATA[Source: National Cancer Institute A bellwether moment in the history of cancer prevention came in 2006 when the Food and Drug Administration (FDA) approved the first vaccine to prevent cervical cancer. The vaccine, Gardasil, protects against the two primary cancer-causing, or oncogenic, types of the human papillomavirus (HPV)—HPV-16 and HPV-18. These types are responsible for [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/use-and-acceptance-of-hpv-vaccine-still-a-work-in-progress/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Test Markets Reveal Women Choose Dissolvable Tobacco</title>
		<link>http://oralcancernews.org/wp/test-markets-reveal-women-choose-dissolvable-tobacco/</link>
		<comments>http://oralcancernews.org/wp/test-markets-reveal-women-choose-dissolvable-tobacco/#comments</comments>
		<pubDate>Tue, 22 Nov 2011 17:33:04 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Camel]]></category>
		<category><![CDATA[cigarettes]]></category>
		<category><![CDATA[dissolvable tobacco]]></category>
		<category><![CDATA[Family Smoking Prevention]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Marlboro]]></category>
		<category><![CDATA[Philip Morris]]></category>
		<category><![CDATA[R.J. Reynolds Tobacco Co.]]></category>
		<category><![CDATA[smokeless tobacco]]></category>
		<category><![CDATA[Tobacco Control Act]]></category>
		<category><![CDATA[Tobacco Products Scientific Advisory Committee]]></category>
		<category><![CDATA[Virginia Slims]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12110</guid>
		<description><![CDATA[Source: Convenience Store News WINSTOM-SALEM, N.C. &#8212; Since starting a second round of testing, R.J. Reynolds Tobacco Co.&#8217;s dissolvable tobacco products are proving popular among women. The product line &#8212; Camel Sticks, Camel Strips and Camel Orbs &#8211;do not require spitting, which could be a deciding factor among female tobacco users. According to a report [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/test-markets-reveal-women-choose-dissolvable-tobacco/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>US FDA approval for expanded use of Erbitux</title>
		<link>http://oralcancernews.org/wp/us-fda-approval-for-expanded-use-of-erbitux/</link>
		<comments>http://oralcancernews.org/wp/us-fda-approval-for-expanded-use-of-erbitux/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 13:24:41 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[5-fluorouracil]]></category>
		<category><![CDATA[apoptosis]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[erbitux]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[infusion]]></category>
		<category><![CDATA[monoclonal antibody]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12055</guid>
		<description><![CDATA[Source: www.pharmabiz.com Author: staff The US Food and Drug Administration (FDA) has approved Erbitux (cetuximab), in combination with platinum-based chemotherapy with 5-fluorouracil (CT), for the first-line treatment of recurrent locoregional or metastatic squamous cell carcinoma of the head and neck (SCCHN). The approval, which is based on data from the landmark EXTREME (ErbituX in first-line [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/us-fda-approval-for-expanded-use-of-erbitux/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>E-Cigarette Controversy</title>
		<link>http://oralcancernews.org/wp/e-cigarette-controversy/</link>
		<comments>http://oralcancernews.org/wp/e-cigarette-controversy/#comments</comments>
		<pubDate>Tue, 08 Nov 2011 20:22:07 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Action on Smoking and Health]]></category>
		<category><![CDATA[American Association of Public Health Physicians]]></category>
		<category><![CDATA[American Cancer Society]]></category>
		<category><![CDATA[American Council on Science and Health]]></category>
		<category><![CDATA[American Heart Association]]></category>
		<category><![CDATA[Boston University School of Public Health]]></category>
		<category><![CDATA[Center for Tobacco-Free Kids]]></category>
		<category><![CDATA[Centers for Disease Control]]></category>
		<category><![CDATA[electronic cigarette]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Harm Reduction Journal]]></category>
		<category><![CDATA[Nicorette gum]]></category>
		<category><![CDATA[nicotine]]></category>
		<category><![CDATA[Royal College of Physicians]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[smoking-cessation program]]></category>
		<category><![CDATA[University of Catania]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12044</guid>
		<description><![CDATA[Source: The New York Times If you want a truly frustrating job in public health, try getting people to stop smoking. Even when researchers combine counseling and encouragement with nicotine patches and gum, few smokers quit. Recently, though, experimenters in Italy had more success by doing less. A team led by Riccardo Polosa of the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/e-cigarette-controversy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves Cetuximab for Metastatic Head and Neck Cancer</title>
		<link>http://oralcancernews.org/wp/fda-approves-cetuximab-for-metastatic-head-and-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/fda-approves-cetuximab-for-metastatic-head-and-neck-cancer/#comments</comments>
		<pubDate>Tue, 08 Nov 2011 19:00:48 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Society of clinical oncology]]></category>
		<category><![CDATA[Bristol-Myers Squibb]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[erbitux]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12042</guid>
		<description><![CDATA[Source: MedScape News Today The US Food and Drug Administration (FDA) has approved cetuximab (Erbitux, Bristol-Myers Squibb ) for use in combination with chemotherapy for the treatment of metastatic head and neck cancer. Data show that when combined with cisplatin-based chemotherapy, cetuximab improved overall survival, compared with chemotherapy alone. According to the researchers, this is [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/fda-approves-cetuximab-for-metastatic-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CDC Committee Recommends Boys Receive HPV Vaccine</title>
		<link>http://oralcancernews.org/wp/cdc-committee-recommends-boys-receive-hpv-vaccine/</link>
		<comments>http://oralcancernews.org/wp/cdc-committee-recommends-boys-receive-hpv-vaccine/#comments</comments>
		<pubDate>Tue, 25 Oct 2011 20:47:57 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[CDC]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Department of Preventative Medicine]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV vaccine for boys]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[sexually transmitted disease]]></category>
		<category><![CDATA[Vanderbilt University]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11966</guid>
		<description><![CDATA[Source: CNN.com A federal government advisory committee voted Tuesday to recommend that boys and young men, from ages 11 to 21, be vaccinated against the human papilloma virus, commonly referred to as HPV. The Centers for Disease Control and Prevention&#8217;s Advisory Committee on Immunization Practices says the vaccine series can be started as early as [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/cdc-committee-recommends-boys-receive-hpv-vaccine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Study Indicates Tobacco Industry Was Aware of Their Own Products Dangers</title>
		<link>http://oralcancernews.org/wp/new-study-indicates-tobacco-industry-was-aware-of-their-own-products-dangers/</link>
		<comments>http://oralcancernews.org/wp/new-study-indicates-tobacco-industry-was-aware-of-their-own-products-dangers/#comments</comments>
		<pubDate>Thu, 29 Sep 2011 19:15:14 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Campaign for Tobacco Free Kids]]></category>
		<category><![CDATA[carcinogenic]]></category>
		<category><![CDATA[cigarette smoke]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Harvard University Center for Global Tobacco Control]]></category>
		<category><![CDATA[lung cancer]]></category>
		<category><![CDATA[Philip Morris USA]]></category>
		<category><![CDATA[polonium-20]]></category>
		<category><![CDATA[radioactive]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11850</guid>
		<description><![CDATA[Source: USA Today Tobacco companies knew for decades that cigarette smoke was radioactive and potentially carcinogenic but kept that information from the public, according to a new study. The tobacco industry began investigations into the possible effects of these radioactive particles, identified as polonium-210, on smokers as early as the 1960s, says the study by UCLA [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/new-study-indicates-tobacco-industry-was-aware-of-their-own-products-dangers/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Are lozenges and other smokeless products safer alternatives to smoking?</title>
		<link>http://oralcancernews.org/wp/are-lozenges-and-other-smokeless-products-safer-alternatives-to-smoking/</link>
		<comments>http://oralcancernews.org/wp/are-lozenges-and-other-smokeless-products-safer-alternatives-to-smoking/#comments</comments>
		<pubDate>Fri, 22 Jul 2011 17:44:37 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Arvia]]></category>
		<category><![CDATA[Camel Orbs]]></category>
		<category><![CDATA[Camel Sticks]]></category>
		<category><![CDATA[Camel Strips]]></category>
		<category><![CDATA[cancer-causing chemicals]]></category>
		<category><![CDATA[CDC]]></category>
		<category><![CDATA[cigarette]]></category>
		<category><![CDATA[electronic cigarettes]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[nicotine]]></category>
		<category><![CDATA[nitrosamines]]></category>
		<category><![CDATA[phillip morris]]></category>
		<category><![CDATA[R.J. Reynolds Tobacco Co.]]></category>
		<category><![CDATA[smokeless tobacco]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11462</guid>
		<description><![CDATA[Source: Pennsylvania&#8217;s Fox News Tobacco company rep David Howard waxes enthusiastic when he talks about a new product his employer, R.J. Reynolds Tobacco Co., has developed: a pellet of finely cured tobacco, binders and flavoring that dissolves in the mouth in 10 minutes. Under test market in two U.S. cities — Denver and Charlotte, N.C. [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/are-lozenges-and-other-smokeless-products-safer-alternatives-to-smoking/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Value of Vaccines</title>
		<link>http://oralcancernews.org/wp/the-value-of-vaccines/</link>
		<comments>http://oralcancernews.org/wp/the-value-of-vaccines/#comments</comments>
		<pubDate>Wed, 29 Jun 2011 16:50:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[anti-vaccince movement]]></category>
		<category><![CDATA[autism]]></category>
		<category><![CDATA[bacterial meningitis]]></category>
		<category><![CDATA[Centers for Disease Control and Prevention]]></category>
		<category><![CDATA[Emerging Infections Programs Network]]></category>
		<category><![CDATA[epilepsy]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Haemophilus influenzae type b]]></category>
		<category><![CDATA[mutliple sclerosis]]></category>
		<category><![CDATA[pneumonia]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11371</guid>
		<description><![CDATA[Source: Medscape.com Vaccines Decrease Rate of Bacterial Meningitis A recent, retrospective study revealed that the incidence of bacterial meningitis decreased by 31% over 10 years, likely the result of vaccinations (Thigpen et al. 2011). In addition, the median age of those infected increased from 30.3 to 41.9 years, evidence that vaccinating the young has protected [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/the-value-of-vaccines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cigarette ads, packages must include oral cancer warnings, says FDA</title>
		<link>http://oralcancernews.org/wp/cigarette-ads-packages-must-include-oral-cancer-warnings-says-fda/</link>
		<comments>http://oralcancernews.org/wp/cigarette-ads-packages-must-include-oral-cancer-warnings-says-fda/#comments</comments>
		<pubDate>Sat, 25 Jun 2011 15:30:12 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[advertising]]></category>
		<category><![CDATA[cancerous lesion]]></category>
		<category><![CDATA[cigarette]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[smokeless tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11345</guid>
		<description><![CDATA[Source: http://www.healthcanal.com/ Author: Craig Palmer, ADA News staff The Food and Drug Administration will require use of a “cancerous lesion on lip” image in cigarette advertising and packaging for its potential to motivate positive behavioral change, influence youth and young adults in particular and inform the public that cigarettes cause oral cancer. Flexing its regulatory [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/cigarette-ads-packages-must-include-oral-cancer-warnings-says-fda/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Glowing Cornell Dots Target Cancer</title>
		<link>http://oralcancernews.org/wp/glowing-cornell-dots-target-cancer/</link>
		<comments>http://oralcancernews.org/wp/glowing-cornell-dots-target-cancer/#comments</comments>
		<pubDate>Wed, 15 Jun 2011 18:14:48 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cornell]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[mouth cancer]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[The Oral Cancer Foundation]]></category>
		<category><![CDATA[throat cancer]]></category>
		<category><![CDATA[tongue cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11271</guid>
		<description><![CDATA[SOURCE: Journal of Clinical Investigation, June 13, 2011 (Ivanhoe Newswire)&#8211; New medical technology is showing that Cornell dots may be a potential cancer diagnostic tool. The U.S Food and Drug Administration (FDA) has recently approved the first clinical trial in humans using Cornell Dots- brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging. [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/glowing-cornell-dots-target-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA to regulate cigarette pack labeling</title>
		<link>http://oralcancernews.org/wp/fda-to-regulate-cigarette-pack-labeling/</link>
		<comments>http://oralcancernews.org/wp/fda-to-regulate-cigarette-pack-labeling/#comments</comments>
		<pubDate>Tue, 24 May 2011 17:10:32 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Journal of Preventive Medicine]]></category>
		<category><![CDATA[cigarette manufacturers]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[nonsmokers]]></category>
		<category><![CDATA[Roswell Park Cancer Institute]]></category>
		<category><![CDATA[smokers]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11152</guid>
		<description><![CDATA[Source: Dr.Bicuspid May 19, 2011 &#8212; Cigarette manufacturers have deceived consumers about the risks of their products for years, and remedial actions are needed so consumers can make informed decisions about the products they purchase, according to researchers from the Roswell Park Cancer Institute (RPCI). The researchers evaluated the messages that cigarette pack labels convey [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/fda-to-regulate-cigarette-pack-labeling/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

